Reliable hormonal effect, unreliable healthspan effect. Adrenal-suppression risk is under-discussed.
DHEA reliably raises androgens but RCTs on outcomes are mixed.
Our read is Limited Research. The mechanistic story is plausible and the early signals are interesting, but the human outcome data is thin: a largely speculative evidence base (32/100) and only thin support (34% consensus). At $15/month, supplementing DHEA is a bet on preliminary science rather than a settled recommendation.
Pulled the public claims about supplementing DHEA from the proponents circulating the claim and weighed them against the more cautious voices (a tracked voice), then cross-checked each against the primary trial and cohort literature and the prevailing clinical guidance. We grade the claim against what the human evidence actually supports, not against how confidently it is stated.
This carries medium risk: interactions, contraindications, and dose sensitivity all matter, so supplementing DHEA is not a casual decision. Loop in a clinician who can see your full history before starting.
A well-designed human outcome trial — the kind that currently does not exist — demonstrating benefit at the doses people actually use.
Mechanistic and trial evidence converge on a real, replicable effect.
The effect size is large enough to matter clinically, not just statistically.
The effect size is large enough to matter clinically, not just statistically.
Mechanistic and trial evidence converge on a real, replicable effect.
The intervention improves the primary outcome at standard doses in healthy adults.
Animal-model results don't translate to the human protocol being recommended.
The headline effect shrinks once you account for trial quality.
The headline effect shrinks once you account for trial quality.
Animal-model results don't translate to the human protocol being recommended.
The headline effect shrinks once you account for trial quality.